Skip to main content
Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research 1/2007

01.01.2007 | Original Paper

Reduction of Concurrent Antipsychotic Prescribing Practices Through the Use of PSYCKES

verfasst von: Thomas Uttaro, Molly Finnerty, Thomas White, Rosanne Gaylor, Lawrence Shindelman

Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

The New York State Office of Mental Health has implemented the browser based Psychiatric Clinical Knowledge Enhancement System (PSYCKES) medication application throughout its inpatient system of care. PSYCKES provides detailed current medication regimens and histories, as well as medication best practices reports at the patient, psychiatrist, ward, and facility levels. South Beach Psychiatric Center (SBPC) has made specific use of a best practices report which details proportions of caseloads and number of patients on two or more concurrent antipsychotic medications. Psychiatrists received extensive application and desktop support and individual and group training was conducted. PSYCKES current and historical medication regimens were reviewed for individual cases and best practices reports were used in psychiatry supervision from January 2004 to March 2005. SBPC psychiatrists achieved marked reductions in the proportions of their caseloads on two or more concurrent antipsychotics. Although we cannot impute causality from this pre–post implementation design, the results of this evaluation suggest that the use of PSYCKES was effective in reducing such regimens for inpatients.
Literatur
Zurück zum Zitat American Psychiatric Association (2004). Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 161(Suppl. Feb), 1–114. American Psychiatric Association (2004). Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 161(Suppl. Feb), 1–114.
Zurück zum Zitat Bauer, M. S. (2002). A review of quantitative studies of adherence to mental health clinical practice guidelines. Harvard Review of Psychiatry, 10(3), 138–153.PubMedCrossRef Bauer, M. S. (2002). A review of quantitative studies of adherence to mental health clinical practice guidelines. Harvard Review of Psychiatry, 10(3), 138–153.PubMedCrossRef
Zurück zum Zitat Clark, R. E., Bartels, S. J., Mellman, T. A., & Peacock, W. J. (2002). Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: Implications for state mental health policy. Schizophrenia Bulletin, 28(1), 75–84.PubMed Clark, R. E., Bartels, S. J., Mellman, T. A., & Peacock, W. J. (2002). Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: Implications for state mental health policy. Schizophrenia Bulletin, 28(1), 75–84.PubMed
Zurück zum Zitat Cohen, T., Kaufman, D., White, T., Segal, G., Bennett-Staub, A., Patel, V., & Finnerty, M. (2004) Cognitive evaluation of an innovative psychiatric clinical knowledge enhancement system. Medinfo, 11, 1295–1299.PubMed Cohen, T., Kaufman, D., White, T., Segal, G., Bennett-Staub, A., Patel, V., & Finnerty, M. (2004) Cognitive evaluation of an innovative psychiatric clinical knowledge enhancement system. Medinfo, 11, 1295–1299.PubMed
Zurück zum Zitat Expert Consensus Guildelines Series (1999). Treatment of schizophrenia 1999. Journal of Clinical Psychiatry, 60(Suppl. 11), 3–80. Expert Consensus Guildelines Series (1999). Treatment of schizophrenia 1999. Journal of Clinical Psychiatry, 60(Suppl. 11), 3–80.
Zurück zum Zitat Finnerty, M., Altmansberger, R., Bopp, J., Carpinello, S., Docherty, J. P., Fisher, W., Jensen, P., Krishnan, P., Mittleman, M., Olfson, M., Tricarico, J., White, T., & Felton, C. (2002). Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. Schizophrenia Bulletin, 28, 85–94.PubMed Finnerty, M., Altmansberger, R., Bopp, J., Carpinello, S., Docherty, J. P., Fisher, W., Jensen, P., Krishnan, P., Mittleman, M., Olfson, M., Tricarico, J., White, T., & Felton, C. (2002). Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. Schizophrenia Bulletin, 28, 85–94.PubMed
Zurück zum Zitat Freudenreich, O., & Goff, D. C. (2002). Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatrica Scandinavia, 106, 323–330.CrossRef Freudenreich, O., & Goff, D. C. (2002). Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatrica Scandinavia, 106, 323–330.CrossRef
Zurück zum Zitat Ganguly, R., Kotzan, J. A., Miller, L. S., Kennedy, K., & Martin, B. C. (2004). Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients. 1998–2000. Journal of Clinical Psychiatry, 65(10), 1377–1388.PubMedCrossRef Ganguly, R., Kotzan, J. A., Miller, L. S., Kennedy, K., & Martin, B. C. (2004). Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients. 1998–2000. Journal of Clinical Psychiatry, 65(10), 1377–1388.PubMedCrossRef
Zurück zum Zitat Gray, J. (2006). Changing physician prescribing behavior. Canadian Journal of Clinical Pharmacology, 13(1), e81-e84.PubMed Gray, J. (2006). Changing physician prescribing behavior. Canadian Journal of Clinical Pharmacology, 13(1), e81-e84.PubMed
Zurück zum Zitat Lerner, V., Libov, I., Kotler, M., & Strous, R. D. (2004). Combination of “atypical” antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28, 89–98.PubMedCrossRef Lerner, V., Libov, I., Kotler, M., & Strous, R. D. (2004). Combination of “atypical” antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28, 89–98.PubMedCrossRef
Zurück zum Zitat Lin, E. H. B., Kayton, W. J., Simon, G. E., Von Korff, M., Bush, T. M., Rutter, C. M., Saunders, K. W., & Walker, A. (1997). Achieving guidelines for treatment of depression in primary care: Is physician education enough? Medical Care, 35(8), 831–842.PubMedCrossRef Lin, E. H. B., Kayton, W. J., Simon, G. E., Von Korff, M., Bush, T. M., Rutter, C. M., Saunders, K. W., & Walker, A. (1997). Achieving guidelines for treatment of depression in primary care: Is physician education enough? Medical Care, 35(8), 831–842.PubMedCrossRef
Zurück zum Zitat Love, R. C., Mackowick, M., Carpenter, D., & Burks, E. J. (2003). Expert consensus-based medication use evaluation criteria for atypical antipsychotic drugs. American Journal of Health System Pharmacy, 60(Dec), 2455–2470.PubMed Love, R. C., Mackowick, M., Carpenter, D., & Burks, E. J. (2003). Expert consensus-based medication use evaluation criteria for atypical antipsychotic drugs. American Journal of Health System Pharmacy, 60(Dec), 2455–2470.PubMed
Zurück zum Zitat Miller, A. L., Chiles, J. A., Chiles, J. K., Crimson, M. L., Rush, A. J., & Shon, S. P. (1999). The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. Journal of Clinical Psychiatry, 60, 649–657.PubMed Miller, A. L., Chiles, J. A., Chiles, J. K., Crimson, M. L., Rush, A. J., & Shon, S. P. (1999). The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. Journal of Clinical Psychiatry, 60, 649–657.PubMed
Zurück zum Zitat New York State Office of Mental Health (2003). Recommendations for the pharmacological management of schizophrenia. Albany, NY: NYS-OMH. New York State Office of Mental Health (2003). Recommendations for the pharmacological management of schizophrenia. Albany, NY: NYS-OMH.
Zurück zum Zitat Schroeder, N. H., Caffey, E. M., & Lorei, T. W. (1979). Antipsychotic drug: Can education change prescribing practices. Journal of Clinical Psychiatry, 40, 186–189.PubMed Schroeder, N. H., Caffey, E. M., & Lorei, T. W. (1979). Antipsychotic drug: Can education change prescribing practices. Journal of Clinical Psychiatry, 40, 186–189.PubMed
Zurück zum Zitat Statistical Analysis Systems, Inc. (2003). SAS Version 9.1.2. Cary, NC: Author. Statistical Analysis Systems, Inc. (2003). SAS Version 9.1.2. Cary, NC: Author.
Zurück zum Zitat Yuzda, M. S. K. (2000). Combination antipsychotics: What is the evidence? Journal of Informed Pharmacotherapy, 2, 300–305. Yuzda, M. S. K. (2000). Combination antipsychotics: What is the evidence? Journal of Informed Pharmacotherapy, 2, 300–305.
Metadaten
Titel
Reduction of Concurrent Antipsychotic Prescribing Practices Through the Use of PSYCKES
verfasst von
Thomas Uttaro
Molly Finnerty
Thomas White
Rosanne Gaylor
Lawrence Shindelman
Publikationsdatum
01.01.2007
Verlag
Springer US
Erschienen in
Administration and Policy in Mental Health and Mental Health Services Research / Ausgabe 1/2007
Print ISSN: 0894-587X
Elektronische ISSN: 1573-3289
DOI
https://doi.org/10.1007/s10488-006-0075-x

Weitere Artikel der Ausgabe 1/2007

Administration and Policy in Mental Health and Mental Health Services Research 1/2007 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.